Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Parathyroid carcinoma].

Gilles Poissonnet1, Laurent Castillo, Alexandre Bozec

  • 1Service d'ORL et de chirurgie de la face et du cou, Centre Antoine-Lacassagne, 33 avenue de Valombrose, 06189 Nice Cedex 2. gilles.poissonnet@cal.nice.fnclcc.fr

Bulletin Du Cancer
|March 29, 2006
PubMed
Summary

Parathyroid carcinoma, a rare endocrine malignancy, requires prompt diagnosis of severe primary hyperparathyroidism. Surgical resection is the primary treatment, with ongoing monitoring for recurrence and metastasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-course immunotherapy in surgically resectable, high risk cutaneous squamous cell carcinoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Intratumoral Radioenhancer Nanoparticle NBTXR3 Followed by Radiotherapy in Head and Neck Cancer: A Phase 1 Dose-Expansion Nonrandomized Clinical Trial.

JAMA otolaryngology-- head & neck surgery·2026
Same author

Atypical laryngeal dyspnoea with life-threatening obstruction: a case report.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2025
Same author

Kinematic handwriting impairments in olfactory dysfunction-related post-acute covid syndrome: short and long-term neurophysiological considerations.

Brain and cognition·2025
Same author

Loss of neuromonitoring signal in thyroid surgery: predictive factors and surgical strategies.

World journal of surgical oncology·2025
Same author

CD206+CD14- Skin-Resident Macrophages and DC-T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma.

Cancer immunology research·2025

Area of Science:

  • Endocrinology
  • Oncology
  • Surgical Pathology

Context:

  • Parathyroid carcinoma is a rare endocrine neoplasm, representing 1-5% of all parathyroid tumors.
  • Diagnosis is often delayed, typically suspected in cases of severe primary hyperparathyroidism with significant hypercalcemia and elevated parathormone levels.
  • A palpable cervical mass may indicate the presence of parathyroid cancer.

Purpose:

  • To outline the diagnostic and therapeutic strategies for parathyroid carcinoma.
  • To emphasize the importance of early suspicion and accurate localization for effective management.
  • To review surgical treatment options and follow-up protocols for parathyroid cancer.

Summary:

  • Parathyroid carcinoma necessitates suspicion in severe primary hyperparathyroidism with marked hypercalcemia and elevated parathormone, often presenting as a palpable neck mass.

Related Experiment Videos

  • Preoperative imaging, including head and neck ultrasonography and 99mTc-sestamibi scintigraphy, aids in tumor localization.
  • The standard surgical treatment involves tumorectomy and hemithyroidectomy with selective neck dissection (level VI), potentially including lateral neck dissection.
  • Postoperative monitoring of calcium and parathormone levels is crucial for assessing tumor control.
  • The risk of local recurrence or metastasis ranges from 30-70%, with a 5-year survival rate of 50-80%.

    • Impact:

    • Improved diagnostic accuracy through recommended imaging modalities.
    • Standardized surgical approach for parathyroid carcinoma, enhancing treatment efficacy.
    • Established follow-up protocols to monitor for recurrence and metastasis, potentially improving patient outcomes.
    • Informed decision-making regarding adjuvant therapies like radiation for recurrent disease.